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ABSTRACT
The 30-peptidyl-tRNA conjugates that possess a
hydrolysis-resistant ribose-30-amide linkage
instead of the natural ester linkage would represent
valuable substrates for ribosomal studies. Up to
date, access to these derivatives is severely
limited. Here, we present a novel approach for the
reliable synthesis of non-hydrolyzable 30-peptidyl-
tRNAs that contain all the respective genuine nu-
cleoside modifications. In short, the approach is
based on tRNAs from natural sources that are site-
specifically cleaved within the T)C loop by using
DNA enzymes to obtain defined tRNA 50-fragments
carrying the modifications. After dephosphorylation
of the 20,30-cyclophosphate moieties from these
fragments, they are ligated to the respective
30-peptidylamino-tRNA termini that were prepared
following the lines of a recently reported solid-phase
synthesis. By this novel concept, non-hydrolyzable
30-peptidyl-tRNA conjugates possessing all natural
nucleoside modifications are accessible in highly
efficient manner.
INTRODUCTION
The chemical synthesis of 30-peptidyl-tRNA conjugates
containing the natural tRNA modiﬁcations represents a
huge challenge from the synthetic chemist’s point of view.
Such bioconjugates, in particular those which possess a
hydrolysis-resistant ribose-30-amide linkage instead of
the natural ester linkage, would ﬁll a missing gap with
respect to ribosomal studies that focus on structural and
functional characterization of pre- and postpeptidyl
transfer states (1–3), of tRNA hybrid states (4–6), of
translation termination (7), of ribosome stalling (8–9)
but also of phenomena like macrolide antibiotic resistance
(10–12), to mention a few examples.
To date, full-length tRNAs without the natural modiﬁ-
cation pattern are accessible either by in vitro transcription
or by chemical RNA synthesis using phosphoramidite
building blocks (13–15). More recent reports, however,
favor the combined approach of enzymatic ligation of
two chemically synthesized half-molecules to obtain
tRNAs in multimilligram amounts with greatly reduced
30-heterogeneity (compared to production via transcrip-
tion by T7 RNA polymerase) (16–17). This approach
also circumvents chemical synthesis of RNA larger than
50–60nt, which is technically challenging.
The drawback of a total synthesis approach for the
tRNA portion of our targets would be that by far not
all naturally occurring tRNA nucleoside modiﬁcations
could be taken into account (18–19). This is simply
because most of the structurally complex modiﬁcations
are not compatible with reaction conditions required for
RNA solid-phase synthesis. Another aspect that we con-
sidered for our endeavors toward fully modiﬁed, non-
hydrolyzable 30-peptidyl-tRNAs was the enzymatic deg-
radation of the tRNA 30-terminus (..C
74C
75A
76-30)t o
yield intermediates with a truncated 30-terminus
(..C
74C
75-30) for enzymatic attachment of 30-amino-
30-deoxyadenosine using the corresponding triphosphate
as precursor (20–21). The resulting tRNA would then
provide a reactive 30-amino group, which can be charged
enzymatically with an amino acid using the cognate tRNA
synthetase (20–23). This method was introduced in the
1970s (20) and has been occasionally applied ever since
(21–23); however, the drawback of the approach is its re-
striction to the attachment of only one amino acid rather
than a polypeptide. A further study from the early 1970s
describes coupling of N-protected amino acid active esters
and anhydrides directly to full-length tRNA (and also to
30-amino-30-deoxy tRNA) to achieve short peptidyl-tRNA
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able in reliable manner to most tRNAs since these
reagents react competitively with functional groups that
are encountered in natural tRNA nucleoside modiﬁca-
tions. Moreover, only weak ester activation can be used
(because of competitive reactivity of the RNA 20-hydroxyl
groups) and thus the disadvantage of long reaction times
together with incomplete coupling are further limitations
that make this method unreliable.
Here, we present a novel approach for the eﬃcient syn-
thesis of non-hydrolyzable 30-peptidyl-tRNAs that contain
all natural tRNA nucleoside modiﬁcations. The basic
concept is outlined in Figure 1. In short, we started
from natural tRNAs that were cleaved within the TC
loop by using DNA enzymes to obtain the tRNA
50-fragment containing all modiﬁcations. After
dephosphorylation of the 20,30-cyclophosphate moiety,
this fragment fulﬁlled the structural requirements for
enzymatic ligation to RNA-peptide conjugates that had
been prepared according to a solid-phase synthesis
approach elaborated previously in our laboratory (12).
MATERIALS AND METHODS
30-Peptidylamino oligoribonucleotides
The peptide-RNA conjugates 6 were prepared by solid-
phase synthesis following Ref. (12). We mention that
this reference includes a signiﬁcant improvement
compared to the original concept introduced by
Strazewski and colleagues (26), that is the alternative syn-
thesis of the 30-aminoacylamino-30-deoxyadenosine key
derivative together with the functionalization of an
advanced solid-support material (GE Healthcare PS200
Support) resulting in signiﬁcantly higher yields and
being less time consuming.
DNA enzyme-mediated tRNA cleavage
Escherichia coli tRNA
Val, E. coli tRNA
Phe and
Saccharomyces cerevisiae tRNA
Phe were purchased from
Sigma Aldrich. All DNA strands were obtained from IDT
(grade: desalted) and directly used without further puriﬁ-
cation. For tRNA cleavage, the tRNA and the appropri-
ate DNA enzyme (substrate recognition domains of 17nt
each) were lyophilized to dryness and dissolved in cleavage
buﬀer [50mM Tris–HCl (pH 7.5), 10mM MgCl2; for
tRNAs containing thio-modiﬁed nucleosides (e.g. s
4U)
10mM DTT was added]; ctRNA=40mM and
cDNAzyme=80mM (substrate/enzyme=1/2). Several
rounds of thermal cycling using a heating block
(ThermostatPlus; Eppendorf) were performed
[S. cerevisiae tRNA
Phe: 1min at 90 C, 5min at 60 C,
15min at 25 C (three rounds); E. coli tRNA
Val and
tRNA
Phe: 1min at 90 C, 5min at 60 C, 10min at 35 C,
10min at 25 C (three rounds), then 5min at 60 C and
80min at 25 C]. The reaction was stopped by freezing in
liquid nitrogen.
Monitoring of the cleavage reaction was performed by
anion-exchange chromatography on a Dionex
DNAPacPA-100 column (4 250mm) at 60 C (80 C
for E. coli tRNA
Val). Flow rate: 1ml/min; eluant A:
25mM Tris–HCl (pH 8.0), 6M urea; eluant B: 25mM
Tris–HCl (pH 8.0), 6M urea, 500mM NaClO4; gradient:
0–60% B in A within 45min; UV detection at 260nm. The
obtained tRNA fragments were puriﬁed on a semi-
preparative Dionex DNAPac

PA-100 column
(9 250mm) at 60 C (80 C for E. coli tRNA
Val). Flow
rate: 2ml/min; gradient: 28–40% B in A within 20min.
Fractions containing the 50-terminal tRNA fragment
were loaded on a C18 SepPak

Plus cartridge (Waters/
Millipore), washed with 0.1–0.2MðEt3NHÞ
+HCO
 
3 ,H2O
and eluted with H2O/CH3CN (1/1, v/v). The solvent was
removed in vacuo and the puriﬁed RNA was dissolved in
1.0ml of nanoﬁltered water. The yields of RNA were
determined as units of optical density at 260nm by UV
spectroscopy (Varian Cary 100) at room temperature.
Figure 1. Hydrolysis-resistant 30-peptidyl-tRNA conjugates. (a) Crucial
structural feature of an exemplary target: The amide linkage (high-
lighted in red). (b) Cartoon presentation of a 30-peptidyl-tRNA conju-
gate. Typical positions of natural chemical modiﬁcations are shown in
red (PDB coordinates 1EVV: S. cerevisiae tRNA
Phe). The 30-terminal
sequences (18nt) of tRNAs are generally unmodiﬁed (blue); arrow
(cyan) indicates the intended site of tRNA cleavage (by using DNA
enzymes) and the site of ligation (to synthetic 30-peptidylamino-RNA
conjugates); (c) concept for the semi-synthesis of non-hydrolyzable
30-peptidyl-tRNA conjugates (for explanation see main text).
Modiﬁed nucleosides, N; cyclophosphate, cp; phosphate, p.
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Aliquots of stock solutions that contained the 50-terminal
tRNA 20,30-cyclophosphates were lyophilized to dryness
and dissolved in nanoﬁltered water (about two-third of
the ﬁnal total reaction volume, cRNAcp=15mM). The
solution was heated to 90 C for 1min and then allowed
to cool to room temperature within 15min. Subsequently,
one-tenth of the ﬁnal reaction volume of reaction buﬀer
[700mM Tris–HCl (pH 7.6), 100mM MgCl2,5 0 m M
DTT=‘10  reaction buﬀer’] was added to the mixture.
The sample was vortexed and centrifuged before it was
treated with T4 polynucleotide kinase (T4 PNK,
Promega; 10U/ml in storage solution) to give a concentra-
tion of 0.5U/ml for S. cerevisiae tRNA ligation and
1.0U/ml for E. coli tRNA ligation, respectively, in the
ﬁnal reaction volume. After addition of water to obtain
the concentration of 15mMo f5 0-terminal tRNA
20,30-cyclophosphate, the reaction solution was vortexed
again and incubated at 37 C for 6–24h. Then, the
reaction mixture was extracted twice with an equal
volume of a phenol/chloroform/isoamyl alcohol solution
(25/24/1, v/v/v) and twice with an equal volume of chloro-
form/isoamyl alcohol solution (24/1, v/v). All organic
layers were rewashed once with an equal volume of
nanoﬁltered water; the aqueous phases were combined
and lyophilized in vacuo. Monitoring of the
dephosphorylation reaction was performed by anion-
exchange chromatography on a Dionex DNAPac

PA-
100 column (4 250mm) at 60 C under the same condi-
tions as described above.
Enzymatic ligation with T4 RNA ligase
Ligation without DNA splint. Equimolar amounts of
acceptor and donor strands (ﬁnal RNA concentration =
40mM each strand) were mixed in nanoﬁltered water
(about two-third of the ﬁnal total reaction volume), the
solution was heated to 90 C for 2min and then allowed to
cool to room temperature within 15min. One-tenth of the
ﬁnal reaction volume of reaction buﬀer [500mM HEPES–
NaOH (pH 8.0), 100mM MgCl2, 100mM DTT = ‘10 
ligation buﬀer’], ATP and BSA from stock solutions were
added to the mixture to give concentrations of 1mM ATP
and 0.1mg/ml BSA (in the ﬁnal reaction volume). The
sample was vortexed and centrifuged before it was
treated with T4 RNA ligase (Fermentas; 10U/mli n
storage solution) to give a concentration of 0.5 U/ml (in
the ﬁnal reaction volume). After addition of water to
obtain the ﬁnal reaction volume, the reaction solution
was vortexed again and incubated at 37 C for 3h.
Ligation with DNA splint. Equimolar amounts of
acceptor, donor and DNA strands (ﬁnal concentration
=40mM each strand) were mixed in nanoﬁltered water
(about two-third of the ﬁnal total reaction volume), the
solution was heated to 90 C for 2min and then allowed to
cool to room temperature within 15min. One-tenth of the
ﬁnal reaction volume of reaction buﬀer [500mM HEPES–
NaOH (pH 8.0), 100mM MgCl2, 100mM DTT=‘10 
ligation buﬀer’], ATP and BSA from stock solutions
were added to the mixture to give concentrations of
0.5mM ATP and 0.1mg/ml BSA (in the ﬁnal reaction
volume). The sample was vortexed and centrifuged
before it was treated with T4 RNA ligase (Fermentas;
10U/ml in storage solution) to give a concentration of
0.25U/ml (in the ﬁnal reaction volume). After addition
of water to obtain the ﬁnal reaction volume, the reaction
solution was vortexed again and incubated at 37 C for 3h.
General work-up. The reaction mixture was extracted
twice with an equal volume of a phenol/chloroform/
isoamyl alcohol solution (25/24/1, v/v/v) and twice with
an equal volume of chloroform/isoamyl alcohol solution
(24/1, v/v). All organic layers were rewashed once with an
equal volume of nanoﬁltered water; the aqueous phases
were combined and reduced by  50%. Monitoring of the
ligation reaction and puriﬁcation of the product were per-
formed by anion-exchange chromatography on a Dionex
DNAPacPA-100 column (4 250mm or 9 250mm;
gradient for puriﬁcation: 31–44% B in A within 20min)
at 60 C under the same conditions as described above.
LC-ESI mass spectrometry
All experiments were performed on a Finnigan LCQ
Advantage MAX ion trap instrumentation (Thermo
Fisher Scientiﬁc) connected to an Amersham Ettan
Micro HPLC system (GE Healthcare). Oligonucleotides
were analyzed in the negative-ion mode with a potential
of  4kV applied to the spray needle. Oligonucleotides
(100–160pmol) in stock solution were dried in vacuo and
redissolved in 30ml of 20mM EDTA solution; column
(XTerraMS, C18, particle size 2.5mm, 1.0 50mm;
Waters) at 21 C; ﬂow rate: 30ml/min; eluant A: 8.6mM
triethylamine, 100mM 1,1,1,3,3,3-hexaﬂuoroisopropanol
in H2O (pH 8.0); eluant B: methanol; gradient: 0–100%
B in A within 20min; UV detection at 254nm. Prior to
each injection, column equilibration was performed by
buﬀer A for 30min at a ﬂow rate of 30ml/min.
RESULTS AND DISCUSSION
tRNA cleavage in the T)C loop by DNA enzymes
For the ﬁrst step of our undertaking, namely the DNA
enzyme catalyzed cleavage of tRNA, we chose natural
tRNA together with synthetic 10–23 type DNA enzymes
(27). The site of tRNA cleavage was placed between A58
and U59 for two reasons. First, these nucleosides are
highly conserved and represent an established dinucleotide
sequence for cleavage by 10–23 DNA enzymes
(50-..AU..-30) (28,29) and second, they provide ideal
nucleobase termini (purine at the 30-end of the acceptor
strand and pyrimidine at the 50-end of the donor strand)
for high-yield enzymatic ligation using T4 RNA ligase
later on (30,31). Furthermore, this cleavage site has
the advantage that the resulting 58-nt tRNA 50-fragment
contains all natural modiﬁcations, while the remain-
ing 18-nt tRNA 30-fragment that is generally
unmodiﬁed in tRNA can be disposed. The A58/U59
site provides another convenience with respect to the
ligation of 30-amino-30-deoxyribose-linked RNA-peptide
conjugates: from previous studies (12), we experienced
6798 Nucleic Acids Research, 2010,Vol.38, No. 19that the RNA portion should contain about the same
number of nucleoside units (or more) compared to the
number of amino acids of the peptide portion to make
these compounds unrestrictedly water soluble. In this
sense, we were conﬁdent to be able to attach the
peptides of our interest to tRNA, which are in particular
dipeptides (of varying sequence) and macrolide-resistance
peptides (pentapeptides) (10,11).
To evaluate our concept we chose three commercially
available tRNAs, namely E. coli tRNA
Val, E. coli
tRNA
Phe and S. cerevisiae tRNA
Phe. Figure 2 shows the
exemplary cleavage of E. coli tRNA
Val 1 by the 10–23
DNA enzyme 2 with 17-nt long recognition arms.
Temperature cycles were required to push tRNA
cleavage almost toward completeness within 3h (for
details see ‘Materials and Methods’ section). The tRNA
50-fragment 3 was puriﬁed by anion-exchange chromatog-
raphy under denaturing conditions and the correct mo-
lecular weight was conﬁrmed by LC-ESI mass
spectrometry. Also for E. coli tRNA
Phe and S. cerevisiae
tRNA
Phe, cleavage by the corresponding 10–23 DNA
enzymes was very eﬃcient (see Supplementary Data). It
is noteworthy that S. cerevisiae tRNA
Phe possesses
N1-methyladenosine as a modiﬁed nucleoside directly at
the site of cleavage, which is tolerated by the DNA
enzyme.
Dephosphorylation
The tRNA 50-fragments that were obtained by 10–23
DNA enzyme cleavage carried 20,30-cyclophosphate
groups. These termini cannot be used as substrates for
the intended enzymatic ligation to synthetic
30-peptidylamino-RNA conjugates using T4 RNA ligase.
Therefore, we applied T4 PNK that is known to have
30-phosphatase activity to release the cyclophosphate and
to generate terminal ribose moieties with free 20-OH and
30-OH groups (32). The enzymatic reaction proceeded
smoothly within 6h for the tRNA 50-fragments 3 of
E. coli tRNA
Phe (Figure 3) and S. cerevisiae tRNA
Phe
20,30-cyclophosphates (Supplementary Data), but
required longer reaction times (24h) and higher enzyme
concentrations for E. coli tRNA
Val derived fragment 3
(Supplementary Data). We speculate that a signiﬁcantly
stable misfold of E. coli tRNA
Val fragment 3 could be the
reason to retard recognition by the enzyme. The tRNA
50-fragments 5 were puriﬁed by phenol/chloroform extrac-
tion and the correct molecular weight was conﬁrmed by
Figure 2. Example for the cleavage of a natural tRNA by DNA
enzymes. (a) Secondary structure of E. coli tRNA
Val 1 and 10–23
DNA enzyme 2. The desired tRNA 50-fragment 3 contains all
modiﬁed nucleosides and possesses a 20,30-cyclophosphate terminus.
(b) Anion-exchange HPLC analysis of the cleavage reaction (88%
yield according to peak area integration) and the puriﬁed fragment;
reaction conditions: cDNAzyme=80mM; ctRNA=40mM; 50mM
Tris–HCl (pH 7.5), 10mM MgCl2, 10mM DTT, temperature cycles
(25–90 C); anion-exchange HPLC: for conditions see ‘Materials and
Methods’ section. (c) LC-ESI MS analysis of 3: m.w. (calcd)=19113,
m.w. (found)=19112±10. For structures and abbreviations of
modiﬁed nucleosides, see Supplementary Data.
Figure 3. Example for enzymatic dephosphorylation of the
20,30-cyclophosphate at the tRNA 50-fragment. (a) Structure of the
50-fragment from E. coli tRNA
Phe 20,30-cyclophosphate 3 and product
5 after exposure to T4 PNK. (b) The PNK reaction was monitored by
anion-exchange HPLC analysis. The diﬀerence in retention time
between 3 and 5 is marginal; reaction conditions: T4 PNK (0.5U/ml;
cRNA=15mM; 70mM Tris–HCl (pH 7.6), 10mM MgCl2, 5mM DTT,
37 C. (c) LC-ESI MS analysis of 5: m.w. (calcd)=19045, m.w.
(found)=19046±10. Anion-exchange HPLC: for conditions see
‘Materials and Methods’ section. For structures and abbreviations of
modiﬁed nucleosides see Supplementary Data.
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types of tRNA tested, the diﬀerence in HPLC retention
times between educt 3 and product 5 was either very slight
or could not be resolved at all. Therefore, we recommend
MS analysis for product veriﬁcation in any case (Figure 3
and Supplementary Data).
Enzymatic ligation of 30-peptidylamino-tRNA
Having the desired tRNA 50-fragments 5 with all natural
modiﬁcations in our hands, we moved on to the ﬁnal step,
namely enzymatic ligation with synthetic
30-peptidylamino-RNA conjugates 6 to yield the target
compounds 8. The usage of T4 RNA ligase seemed appro-
priate since the 18-nt RNA portion of the synthetic con-
jugate was expected to form a perfectly base paired and
suﬃciently stable preligation complex to bring the
50-phosphate of the donor strand 6 (synthetic conjugate)
in close proximity to the 30-OH group of the acceptor
strand 5 (58-nt tRNA fragment). This is a prerequisite
for eﬃcient ligation with T4 RNA ligase (30,31,33–36).
Figure 4 depicts the ligation set-up for E. coli tRNA
Phe.
The two strands 5 and 6 aligned properly and eﬃcient
ligation was observed after 3h. The full-length
tRNA-peptide conjugate 8 was puriﬁed by
anion-exchange chromatography and the correct molecu-
lar weight was conﬁrmed by LC-ESI mass spectrometry.
Unexpectedly, the analogous experimental set-up did not
work for E. coli tRNA
Val and S. cerevisiae tRNA
Phe
(Figure 5). However, when using the non-modiﬁed
tRNA sequence homologues of 5 in combination with syn-
thetic conjugates 6, ligation worked eﬃciently. To ration-
alize this behavior two scenarios are conceivable: in their
natural counterparts, the nucleoside modiﬁcations of these
particular tRNA fragments 5 either stabilize structures (of
5), which render proper alignment with 6 impossible, or
the binary preligation complex of 5 and 6 can form but is
stabilized by the modiﬁcations in such a manner (tRNA
tertiary fold) that the ‘nicked’ tRNA is no longer access-
ible to the ligase. As a resort, we considered splint-
supported ligation with T4 RNA ligase. Indeed, when
we applied the DNA template 7 to the ligation reaction
with S. cerevisiae tRNA
Phe sequences, we observed
ligation of the two fragments with reasonable yields
(Figure 5c). The same holds true for E. coli tRNA
Val
(Supplementary Data).
The DNA splint 7 was designed to bring the nucleotide
termini of 5 and 6 in close proximity by forming a stable
ternary preligation complex (Figure 5a), in analogy to two
reports on RNA ligation in the literature (37,38). We also
tested splints that form a fully base paired, nicked duplex
at the site of ligation, which should be appropriate for
ligation using T4 DNA ligase. However, in the case of
S. cerevisiae tRNA
Phe, no ligation product was detectable,
most likely because N1-methyladenine-58 prevented the
adoption of Watson–Crick base pair geometry at the site
of ligation, which is required for this ligase type (39,40).
Another peculiarity that we observed only for ligations
concerning S. cerevisiae tRNA
Phe was the mass spectro-
metric detection of a 30-peptidylamino-tRNA byproduct
that most likely carried an A-50-pp-50-G(1) terminus
(Supplementary Data). The formation of such a
byproduct can be explained by the T4 RNA ligase
activity (31,41). Consuming ATP, the enzyme transfers
50-p-A to 50-phosphorylated RNA and thereby generates
an adenylated RNA donor intermediate. This activated
species then reacts with the ribose 30-OH of the acceptor
RNA strand. If no acceptor strand is available (or if it
reacts slowly), the A-50-pp-50-RNA intermediate can be
isolated. In our experiments, the formation of the
S. cerevisiae A-50-pp-50-tRNA
Phe byproduct was signiﬁ-
cantly reduced when using only a small excess of ATP
during the ligation reaction and this observation also
supports the suggested structure of the byproduct
(Supplementary Data).
Table 1 summarizes a selection of 30-peptidyl-tRNA
conjugates synthesized in this study and provides their
Figure 4. Example for enzymatic ligation of fully modiﬁed tRNA
50-fragments to synthetic 30-peptidylamino-RNA conjugates. (a)
Structures of the 50-fragment from E. coli tRNA
Phe 5 and the
dipeptide-RNA conjugate 6 to form a preligation complex that allows
T4 RNA ligation of the full-length tRNA-peptide conjugate 8. (b) The
ligation reaction was monitored by anion-exchange HPLC analysis:
83% yield was achieved after 3h; reaction conditions: T4 RNA ligase
(0.5 U/ml; cRNA=40mM each strand; donor/acceptor=1/1), 50mM
HEPES–NaOH (pH 8.0), 10mM MgCl2, 10mM DTT, 1mM ATP,
0.1mg/ml BSA, 37 C. (c) Puriﬁed 30-peptidyl-tRNA; (d) LC-ESI MS
analysis of 8: m.w. (calcd)=25030, m.w. (found)=25029±10.
Anion-exchange HPLC: for conditions see ‘Materials and Methods’
section. For structures and abbreviations of modiﬁed nucleosides see
Supplementary Data.
6800 Nucleic Acids Research, 2010,Vol.38, No. 19total (isolated) amounts. We mention that the average
overall yield is estimated to  20% starting from the
natural tRNA species and considering each of the three
steps of preparation after puriﬁcation.
Conclusions
With the approach presented here, we have laid the basis
for convenient chemical modiﬁcation and labeling of the
30-terminus of natural tRNAs. The use of DNA enzymes
as a tool for tRNA manipulation has been demonstrated
by Helm and coworkers (42,43) for analytical purposes;
however, to the best of our knowledge, DNA enzymes
have not been integrated into synthetic concepts for
tRNA derivatives before. We also mention that our
approach is promising to be applicable to many kinds of
tRNA, which are of diﬀerent amino acid speciﬁcity and
from various organisms. From the three examples shown
here, it becomes evident that ﬁnetuning of the conditions,
e.g. with respect to the length of the recognition arms of
the DNA enzymes or the length of the splint for ligation
might be necessary to optimize yields.
Moreover, the present approach is not restricted to the
type of conjugates shown here, but basically appropriate
for any kind of chemical modiﬁcation that can be attached
and introduced via the 18-nt tRNA terminal sequence.
This will, for example, open up a variety of new positions
for ﬂuorescent labeling of natural tRNAs that have been
largely inaccessible to date. Such tRNAs are of growing
interest for the investigation of ribosome translation
kinetics using single-molecule ﬂuorescence techniques (5).
With the combined synthetic and enzymatic approach,
we have abolished the preparative bottleneck for
hydrolysis-resistant 30-peptidyl-tRNA that are highly re-
quested for ribosomal studies to achieve detailed molecu-
lar insights into structure and dynamics of pre- and
postpeptidyl transfer states and of tRNA hybrid states,
but also of translation termination and ribosome
stalling. Our own research will integrate these conjugates
into investigations on macrolide antibiotic resistance
induced by short resistance peptides (10–12).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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bAfter puriﬁcation.
Nucleic Acids Research, 2010,Vol.38, No. 19 68017. Weixlbaumer,A., Jin,H., Neubauer,C., Voorhees,R.M., Petry,S.,
Kelley,A.C. and Ramakrishnan,V. (2008) Insights into
translational termination from the structure of RF2 bound to the
ribosome. Science, 322, 953–956.
8. Seidelt,B., Innis,C.A., Wilson,D.N., Gartmann,M., Armache,J.P.,
Villa,E., Trabuco,L.G., Becker,T., Mielke,T., Schulten,K. et al.
(2009) Structural insight into nascent polypeptide chain-mediated
translational stalling. Science, 326, 1412–1415.
9. Bhushan,S., Gartmann,M., Halic,M., Armache,J.P., Jarasch,A.,
Mielke,T., Berninghausen,O., Wilson,D.N. and Beckmann,R.
(2010) Alpha-helical nascent polypeptide chains visualized within
distinct regions of the ribosomal exit tunnel. Nat. Struct. Mol.
Biol., 17, 313–317.
10. Mankin,A.S. (2008) Macrolide myths. Curr. Opin. Microbiol, 11,
414–421.
11. Tenson,T. and Mankin,A.S. (2001) Short peptides conferring
resistance to macrolide antibiotics. Peptides, 22, 1661–1668.
12. Moroder,H., Steger,J., Graber,D., Fauster,K., Trappl,K.,
Marquez,V., Polacek,N., Wilson,D.N. and Micura,R. (2009)
Non-hydrolyzable RNA-peptide conjugates: a powerful advance
in the synthesis of mimics for 30-peptidyl tRNA termini. Angew.
Chem. Int. Ed. Engl., 48, 4056–4060.
13. Ogilvie,K.K., Usman,N., Nicoghosian,K. and Cedergren,R.J.
(1988) Total chemical synthesis of a 77-nucleotide-long RNA
sequence having methionine-acceptance activity. Proc. Natl Acad.
Sci. USA, 85, 5764–5768.
14. Perreault,J.P., Pon,R.T., Jiang,M.Y., Usman,N., Pika,J.,
Ogilvie,K.K. and Cedergren,R. (1989) The synthesis and
functional evaluation of RNA and DNA polymers having the
sequence of Escherichia coli tRNA(fMet). Eur. J. Biochem., 186,
87–93.
15. Chaix,C., Duplaa,A.M., Molko,D. and Te ´ oule,R. (1989) Solid
phase synthesis of the 50-half of the initiator t-RNA from B.
subtilis. Nucleic Acids Res., 17, 7381–7393.
16. Sherlin,L.D., Bullock,T.L., Nissan,T.A., Perona,J.J.,
Lariviere,F.J., Uhlenbeck,O.C. and Scaringe,S.A. (2001) Chemical
and enzymatic synthesis of tRNAs for high-throughput
crystallization. RNA, 7, 1671–1678.
17. Miller,J.T., Khvorova,A., Scaringe,S.A. and Le Grice,S.F. (2004)
Synthetic tRNALys,3 as the replication primer for the
HIV-1HXB2 and HIV-1Mal genomes. Nucleic Acids Res., 32,
4687–4695.
18. Grosjean,H. and Benne,R. (eds), (1998) Modiﬁcation and Editing
of RNA. ASM Press, Washington, DC.
19. Bru ¨ ckl,T., Globisch,D., Wagner,M., Mu ¨ ller,M. and Carell,T.
(2009) Parallel isotope-based quantiﬁcation of modiﬁed tRNA
nucleosides. Angew. Chem. Int. Ed. Engl., 42, 7932–7934.
20. Fraser,T.H. and Rich,A. (1973) Synthesis and aminoacylation of
30-amino-3’-deoxy transfer RNA and its activity in ribosomal
protein synthesis. Proc. Natl Acad. Sci. USA, 70, 2671–2675.
21. Sprinzl,M. and Faulhammer,H.G. (1978) Participation of
X47-ﬂuorescamine modiﬁed E. coli tRNAs in in vitro protein
biosynthesis. Nucleic Acids Res., 5, 4837–4840.
22. Ramesh,V., Mayer,C., Dyson,M.R., Gite,S. and
RajBhandary,U.L. (1999) Induced ﬁt of a peptide loop of
methionyl-tRNA formyltransferase triggered by the initiator
tRNA substrate. Proc. Natl Acad. Sci. USA, 96, 875–880.
23. Mayer,C. and RajBhandary,U.L. (2002) Conformational change
of Escherichia coli initiator methionyl-tRNA(fMet) upon binding
to methionyl-tRNA formyl transferase. Nucleic Acids Res., 30,
2844–2850.
24. Lapidot,Y. and de Groot,N. (1972) The chemical synthesis and
the biochemical properties of peptidyl-tRNA. Prog. Nucleic Acid
Res. Mol. Biol., 12, 189–228.
25. Shiloach,J., Lapidot,Y., de Groot,N., Sprinzl,M. and Cramer,F.
(1975) The speciﬁcity of peptidyl-tRNA hydrolase from E. coli.
FEBS Lett., 57, 130–133.
26. Terenzi,S., Biala,E., Nguyen-Trung,N.Q. and Strazewski,P. (2003)
Amphiphilic 30-peptidyl-RNA conjugates. Angew. Chem. Int. Ed.
Engl., 42, 2909–2912.
27. Santoro,S.W. and Joyce,G.F. (1997) A general purpose
RNA-cleaving DNA enzyme. Proc. Natl Acad. Sci. USA, 94,
4262–4266.
28. Ho ¨ bartner,C. and Silverman,S.K. (2007) Recent advances in
DNA catalysis. Biopolymers, 87, 279–292.
29. Silverman,S.K. and Baum,D.A. (2009) Use of deoxyribozymes in
RNA Research. Meth. Enzymol., 469, 95–117.
30. Persson,T., Willkomm,D.K. and Hartmann,R.K. (2005) T4 RNA
ligase. In Hartmann,R.K., Bindereif,A., Scho ¨ n,A. and Westhof,E.
(eds), Handbook of RNA Biochemistry. Wiley-VCH, Weinheim,
Germany, pp. 53–74.
31. Arn,E.A. and Abelson,J. (1998) RNA ligases: function,
mechanism, and sequence conservation. In Simons,R.W. and
Grunberg-Manago,M. (eds), RNA Structure and Function. CSHL
Press, New York, USA, pp. 695–726.
32. Schu ¨ rer,H., Lang,K., Schuster,J. and Mo ¨ rl,M. (2002) A universal
method to produce in vitro transcripts with homogeneous 30 ends.
Nucleic Acids Res., 30, e56.
33. Lang,K. and Micura,R. (2008) The preparation of site-speciﬁcally
modiﬁed riboswitch domains as an example for enzymatic ligation
of chemically synthesized RNA fragments. Nat. Protoc., 3,
1457–1466.
34. Ho ¨ bartner,C. and Micura,R. (2004) The chemical synthesis of
selenium-modiﬁed oligoribonucleotides and their enzymatic
ligation leading to an U6 snRNA stem-loop segment.
J. Am. Chem. Soc., 126, 1141–1149.
35. Ho ¨ bartner,C., Rieder,R., Kreutz,C., Puﬀer,B., Lang,K.,
Polonskaia,A., Serganov,A. and Micura,R. (2005) Syntheses of
RNAs with up to 100 nucleotides containing site-speciﬁc
20-methylseleno labels for use in X-ray crystallography.
J. Am. Chem. Soc., 127, 12035–12045.
36. Rieder,R., Ho ¨ bartner,C. and Micura,R. (2009) Enzymatic ligation
strategies for the preparation of purine riboswitches with
site-speciﬁc chemical modiﬁcations. Riboswitches. Meth. Mol.
Biol., 540, 15–24.
37. Stark,M.R., Pleiss,J.A., Deras,M., Scaringe,S.A. and Rader,S.D.
(2006) An RNA ligase-mediated method for the eﬃcient creation
of large, synthetic RNAs. RNA, 12, 2014–2019.
38. Bain,J.D. and Switzer,C. (1992) Regioselective ligation of
oligoribonucleotides using DNA splints. Nucleic Acids Res., 20, 4372.
39. Moore,M.J. and Query,C.C. (2000) Joining of RNAs by splinted
ligation. Meth. Enzymol., 317, 109–123.
40. Kurschat,W., Mu ¨ ller,J., Wombacher,R. and Helm,M. (2005)
Optimizing splinted ligation of highly structured small RNAs.
RNA, 11, 1909–1914.
41. Bruce,A.G. and Uhlenbeck,O.C. (1978) Reactions at the termini
of tRNA with T4 RNA ligase. Nucleic Acids Res., 5, 3665–3677.
42. Hengesbach,M., Meusburger,M., Lyko,F. and Helm,M. (2008)
Use of DNAzymes for site-speciﬁc analysis of ribonucleotide
modiﬁcations. RNA, 14, 180–187.
43. Hengesbach,M., Voigts-Hoﬀmann,F., Hofmann,B. and Helm,M.
(2010) Formation of a stalled early intermediate of pseudouridine
synthesis monitored by real-time FRET. RNA, 16, 610–620.
6802 Nucleic Acids Research, 2010,Vol.38, No. 19